StockData
CVS HEALTH Corp logo

CVS HEALTH Corp (CVS) KPIs and segments

CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/3012% above fair value
$85.81−2.78 (-3.14%)

Close on Nov 17, 2026Market cap $109.75BP/E 22.8Yield 3.10%

KPI & bộ phận

Chỉ số vận hành và bộ phận làm nên hoạt động của Cvs Health · năm tài chính kết thúc ngày 31 tháng 12

Nhìn nhanh KPI của Cvs Health: 46 chỉ số vận hành, trong đó có Health Care Benefits (Aetna), Health Care Benefits và Health Care Benefits, lấy từ 359 tài liệu nguồn, cùng doanh thu theo bộ phận, sản phẩm và khu vực từ hồ sơ SEC. Mỗi số đều dẫn tới tài liệu gốc. Tất cả chỉ số hiện cả bảng; Cốt lõi chỉ giữ bộ phận và KPI nổi bật. Bảng bộ phận còn có cách xem lũy kế 12 tháng.

Biểu đồ đang trống. Tick vào ô cạnh bất kỳ chỉ số nào ở bảng dưới để vẽ — tick nhiều chỉ số để so sánh trên cùng một biểu đồ.

Bộ phận, KPI nổi bật và mọi chỉ số vận hành từ hồ sơ, thông cáo kết quả và bản trình bày.

Thêm vào biểu đồChỉ số
Q3 2026
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Q2 2024
Q1 2024
Q4 2023
Health Services($M)
51,79548,23751,24449,26646,45343,46247,02044,12942,17140,28549,146
Health Care Benefits($M)
37,53835,97136,29335,99336,25834,81032,95832,99632,47532,23626,726
Pharmacy & Consumer Wellness($M)
33,81631,98937,66036,21433,58131,91233,51432,42329,83828,72531,185
Products($M)
66,21962,22667,04264,59060,60757,66961,91159,67456,21253,72465,154
Services($M)
4,1193,8354,0403,9303,6263,5794,1314,2793,9613,8683,316
Health Care Benefits($M)
2,4263,041-6763141,3081,993-439-924938732676
Health Services($M)
1,7331,4891,9232,0501,5751,6031,7612,2041,9151,3631,860
Pharmacy & Consumer Wellness($M)
1,4751,1971,9111,4781,3381,3131,7581,5961,2431,1772,027
Health Care Benefits($M)
37,53835,97136,29335,99336,25834,81032,95832,99632,47532,236
Pharmacy & Consumer Wellness($M)
6,5346,1997,0826,5676,0276,1086,8046,3916,0035,965
Health Services($M)
3,8873,5184,0354,0363,3733,3473,6623,7483,4062,753
Stores1
Pharmacy & Consumer Wellness
9,0009,0009,0009,0009,0009,0009,0009,000
Health Care Benefits (Aetna) — Total Medical Membership7
26,023.0026,005.0026,591.0026,703.0026,721.0027,079.0027,095.0027,148.0026,970.0026,770.0025,659.00
Total Insured Medical Membership
9,829.009,767.0010,868.0011,001.0011,069.0011,417.0012,514.0012,557.0012,428.0012,212.0011,128.00
Total ASC (Self-Insured) Medical Membership
16,194.0016,238.0015,723.0015,702.0015,652.0015,662.0014,581.0014,591.0014,542.0014,558.0014,531.00
Commercial Medical Membership (Total)2
18,320.0018,334.0018,797.0018,850.0018,859.0019,211.0018,851.0018,906.0018,801.0018,846.0018,339.00
Commercial — Insured
2,487.002,462.003,447.003,536.003,608.003,961.004,691.004,751.004,702.004,735.004,252.00
Commercial — ASC
15,833.0015,872.0015,350.0015,314.0015,251.0015,250.0014,160.0014,155.0014,099.0014,111.0014,087.00
Medicare Advantage Medical Membership (Insured / Total)
4,202.004,175.004,267.004,266.004,240.004,220.004,447.004,438.004,342.004,205.003,460.00
Medicare Supplement Membership (Insured / Total)
1,176.001,192.001,202.001,221.001,236.001,253.001,282.001,291.001,294.001,300.001,343.00
Medicaid Medical Membership (Total)2
2,325.002,304.002,325.002,366.002,386.002,395.002,515.002,513.002,533.002,419.002,517.00
Medicaid — Insured
1,964.001,938.001,952.001,978.001,985.001,983.002,094.002,077.002,090.001,972.002,073.00
Medicaid — ASC
361.00366.00373.00388.00401.00412.00421.00436.00443.00447.00444.00
Medicare Part D Standalone Prescription Drug Plan (PDP) Membership
3,870.003,889.004,041.004,056.004,065.004,094.004,882.004,898.004,903.004,947.006,081.00
Health Care Benefits — Medical Benefit Ratio (MBR %)(%)
87.4%84.6%94.8%92.8%89.9%87.3%94.8%95.2%89.6%90.4%88.5%
Health Care Benefits — Days Claims Payable (DCP, days)(ngày)
4243394341434445434546
Health Services (Caremark PBM) — Pharmacy Claims Processed (30-Day Equivalent)(M)
473465492476469464499484471463601
Health Services (Caremark PBM) — Generic Dispensing Rate (Total %, through FY2024)(%)
86.1%86.8%88.2%88.3%86.2%
Pharmacy & Consumer Wellness (CVS Pharmacy) — Prescriptions Filled (30-Day Equivalent)(M)2
457451474461438436446432420418432
Same-Store Prescription Volume Growth (%, 30-Day Equivalent)(%)
7.0%6.8%9.7%8.9%6.4%6.7%5.9%9.1%6.5%5.8%4.4%
Pharmacy & Consumer Wellness — Generic Dispensing Rate (%, through FY2024)(%)
87.4%88.2%90.1%90.1%86.6%
Pharmacy & Consumer Wellness — Total Same-Store Sales Growth (% YoY)(%)2
2.6%2.8%16.0%14.3%15.4%14.2%10.2%15.5%6.4%5.3%11.3%
Pharmacy Same-Store Sales Growth (% YoY)(%)
2.9%3.1%19.3%16.8%18.1%17.7%13.0%19.5%9.1%7.3%15.5%
Front Store Same-Store Sales Growth (% YoY)(%)
1.0%1.2%0.5%1.5%3.4%-0.3%-1.2%-1.1%-4.0%-2.2%-3.1%
Health Care Benefits (Aetna) — Total Segment Revenues($M)2
37,53835,97136,29335,99336,25834,81032,95832,99632,47532,23626,726
Health Care Benefits — Premium Revenues (Total)($M)2
35,11933,79234,01833,73934,18432,80830,90230,91430,65430,37925,065
Government Premiums (Medicare Advantage, Medicare Supplement, PDP & Medicaid)($M)
28,49427,78326,56225,96825,93024,90222,16422,33122,22221,71617,414
Commercial Insured Premiums($M)
6,6256,0097,4567,7718,2547,9068,7388,5838,4328,6637,651
Health Care Benefits — Net Investment Income($M)
508462475513407387397423300353209
Health Care Benefits — Adjusted Operating Income (Loss)($M)6
2,4263,041-6763141,3081,993-439-924938732676
Health Care Benefits — Adjusted Operating Margin (%)(%)
6.5%8.5%-1.9%0.9%3.6%5.7%-1.3%-2.8%2.9%2.3%2.5%
Health Care Benefits — GAAP Operating Income (Loss)($M)
2,1912,806-936531,0021,674-757-1,229574428266
Health Care Benefits — GAAP Operating Margin (%)(%)
5.8%7.8%-2.6%0.1%2.8%4.8%-2.3%-3.7%1.8%1.3%1.0%
Health Care Benefits — Health Care Costs (Benefit Costs)($M)
30,69228,57932,25331,31930,74028,63729,30029,44327,45827,45822,175
Health Care Benefits — Operating Expenses($M)
4,6554,5864,9764,6214,5164,4994,4154,7824,4434,3504,285
Health Care Benefits — Operating Expense Ratio (% of Revenues)(%)
12.4%12.7%13.7%12.8%12.5%12.9%13.4%14.5%13.7%13.5%16.0%
Health Services (Caremark PBM & Care Delivery) — Total Segment Revenues($M)4
51,79548,23751,24449,26646,45343,46247,02044,12942,17140,28549,146
Health Services Revenue by Channel — Pharmacy Network($M)
26,61725,14927,58826,40824,66523,11425,20224,13621,84820,46429,668
Health Services Revenue by Channel — Mail & Specialty (Mail Choice)($M)
22,57720,50621,26320,39219,61118,06818,75017,21417,65117,26217,614
Health Services Revenue by Channel — Net Investment Income (Loss)($M)
-110-1-314288-1-2-1
Health Services Revenue by Source — Services($M)
2,5802,5112,4322,5002,2332,3132,7132,9222,6812,5681,910
Health Services — Adjusted Operating Income($M)9
1,7331,4891,9232,0501,5751,6031,7612,2041,9151,3631,860
Health Services — Adjusted Operating Margin (%)(%)
3.3%3.1%3.8%4.2%3.4%3.7%3.7%5.0%4.5%3.4%3.8%
Health Services — GAAP Operating Income($M)
1,6031,3471,790-3,8991,1021,2271,9032,0551,7661,2131,710
Health Services — GAAP Operating Margin (%)(%)
3.1%2.8%3.5%-7.9%2.4%2.8%4.0%4.7%4.2%3.0%3.5%
Health Services — Gross Profit($M)
2,5372,2162,6402,7452,2722,3002,6832,8122,6152,0522,535
Health Services — Gross Margin (%)(%)
4.9%4.6%5.2%5.6%4.9%5.3%5.7%6.4%6.2%5.1%5.2%
Health Services — Cost of Products Sold($M)
47,90844,71947,20945,23043,08040,11543,35840,38138,76537,53245,999
Health Services — Health Care Costs (Oak Street Capitated Medical Costs)($M)
1,3501,3021,3951,2911,1011,047979936791701612
Health Services — Operating Expenses($M)
9348698509191,1701,073780757849839825
Health Services — Operating Expense Ratio (% of Revenues)(%)
1.8%1.8%1.7%1.9%2.5%2.5%1.7%1.7%2.0%2.1%1.7%
Pharmacy & Consumer Wellness (CVS Pharmacy) — Total Segment Revenues($M)4
33,81631,98937,66036,21433,58131,91233,51432,42329,83828,72531,185
Pharmacy & Consumer Wellness Revenue by Line — Pharmacy($M)
27,78126,12331,37530,42827,63126,07627,22426,66624,01322,78424,740
Pharmacy & Consumer Wellness Revenue by Line — Front Store($M)
5,4075,2595,6565,1925,3685,2435,6755,1965,2815,3705,861
Pharmacy & Consumer Wellness Revenue by Source — Products($M)
33,15231,33936,84535,50332,94231,28532,83331,82329,25228,12030,534
Pharmacy & Consumer Wellness Revenue by Source — Services($M)
664650815711639627681600586605652
Pharmacy & Consumer Wellness — Adjusted Operating Income($M)6
1,4751,1971,9111,4781,3381,3131,7581,5961,2431,1772,027
Pharmacy & Consumer Wellness — Adjusted Operating Margin (%)(%)
4.4%3.7%5.1%4.1%4.0%4.1%5.2%4.9%4.2%4.1%6.5%
Pharmacy & Consumer Wellness — GAAP Operating Margin (%)(%)
4.2%3.5%4.9%3.9%2.2%2.7%5.1%2.4%4.0%3.9%6.3%
Pharmacy & Consumer Wellness — Gross Margin (%)(%)
19.3%19.4%18.8%18.1%17.9%19.1%20.3%19.7%20.1%20.8%22.6%
Pharmacy & Consumer Wellness — Cost of Products Sold($M)
27,28225,79030,57829,64727,55425,80426,71026,03223,83522,76024,146
Pharmacy & Consumer Wellness — Operating Expenses($M)
5,1235,0655,2365,1535,2915,2445,1104,8604,8244,8525,078
Pharmacy & Consumer Wellness — Operating Expense Ratio (% of Revenues)(%)
15.1%15.8%13.9%14.2%15.8%16.4%15.2%15.0%16.2%16.9%16.3%
Consolidated — Adjusted Operating Income($M)3
5,1575,1502,5973,4593,8084,5792,7282,5473,7442,9574,227
Consolidated — Adjusted Income Attributable to CVS Health($M)
3,3243,2921,3872,0372,3042,8441,5061,3692,3061,6572,738
Consolidated — Adjusted Diluted EPS ($/share)($)
2.582.571.091.601.812.251.191.091.831.312.12
Consolidated — Intersegment Revenue Eliminations($M)
-17,200-15,897-19,626-18,735-17,473-15,729-15,865-14,262-13,361-12,924-13,319
Health Care Costs Payable, Net of Reinsurance (Actuarial Rollforward)($M)6
16,20315,40415,32915,30014,29614,56514,98414,52113,85014,38712,067
IBNR (Incurred But Not Reported) Claims Liability($M)
10,60010,60010,60010,40010,70011,00010,60011,000
Reinsurance Recoverables on Unpaid Claims($M)
112132909410311481655945
Total Incurred Health Care Costs in Reserve Rollforward($M)2
31,40429,28133,70432,12530,80328,64230,13129,18127,78227,73322,450
Incurred Health Care Costs — Current Year($M)
31,55330,37433,76032,15131,05230,29330,23329,36427,96528,21222,456
Incurred Health Care Costs — Prior Years Development (Favorable / Unfavorable)($M)
-149-1,093-56-26-249-1,651-102-183-183-479-6
Claims Paid — Current Year Incurred($M)
29,75218,25533,33630,89629,47919,31230,22728,13826,95516,26322,577
Claims Paid — Prior Years Incurred($M)
85310,9513392251,5939,749-5593721,3649,150378
Health Care Costs Payable Assumed in Acquisitions / Dispositions($M)
000
Direct Premiums Earned (Reinsurance Schedule)7
Premiums Receivable, Net($M)
6,3957,6335,7534,8785,8856,2104,7313,9424,4305,4203,714
Deferred Acquisition Costs (DAC) Balance($M)2
1,9171,8811,8371,7941,7471,6901,6271,5601,502
DAC Capitalized Additions($M)
127127129133139134137134134
DAC Amortization Expense($M)
918386868271707669
Statutory Capital & Surplus Required by Insurance Regulators($M)
11,71011,6919,011
Maximum Statutory Dividend Capacity Without Prior Regulatory Approval($M)
3,7881,5613,098
Self-Insurance Accrual Liability($M)
1,2001,1001,100
Separate Account Policyholder Deposits($M)
220226206236303231229201203
Separate Account Policyholder Benefits Paid($M)
239241230243272257226223224
Available-for-Sale (AFS) Debt Securities — Fair Value($M)7
29,34928,39128,71827,83526,55426,04426,03326,49023,83122,62621,713
AFS Debt Securities — Amortized Cost($M)
29,56428,59328,60027,70526,65626,34526,56226,43324,54823,30822,282
AFS Debt Securities — Gross Unrealized Gains($M)
207245449462347246178510146191267
AFS Debt Securities — Gross Unrealized Losses($M)
422447331332449547707453863873836
AFS Debt Securities Maturing Within 1 Year (Fair Value)($M)
1,1688528178389631,1897618161,3491,2451,230
AFS Debt Securities Maturing in 1 to 5 Years (Fair Value)($M)
11,75211,53411,69911,51211,07010,67010,51010,5298,7847,8367,390
AFS Debt Securities Maturing in 5 to 10 Years (Fair Value)($M)
5,8805,6855,3824,7834,5644,3854,5784,8904,2884,4634,204
AFS Debt Securities Maturing After 10 Years (Fair Value)($M)
2,9782,9002,8472,7122,5612,7102,9093,0643,3103,7033,802
Total Lease Cost (Note 7 Leases)1
Undiscounted Future Operating Lease Payments (Total)($M)8
19,38721,18922,853
Operating Lease Payments Due in Year 1($M)
2,6262,6832,716
Operating Lease Payments Due in Year 2($M)
2,4752,5282,559
Operating Lease Payments Due in Year 3($M)
2,3002,3432,369
Operating Lease Payments Due in Year 4($M)
2,0312,1672,181
Operating Lease Payments Due in Year 5($M)
1,7891,9112,024
Operating Lease Payments Due After Year 5($M)
8,1669,55711,004
Total Finance Lease Liabilities($M)
1,3261,3571,3601,3731,3791,391
Finance Lease Right-of-Use Assets, Net($M)
1,0941,1401,229
Long-Term Debt Maturing After Year 5 (Note 10 Borrowings)($M)5
43,29943,55841,685
Long-Term Debt Maturing in Year 1($M)
4,0073,5592,705
Long-Term Debt Maturing in Year 2($M)
3,3794,0073,785
Long-Term Debt Maturing in Year 3($M)
5,0083,3794,008
Long-Term Debt Maturing in Year 4($M)
3,7585,0073,379
Long-Term Debt Maturing in Year 5($M)
4,2583,7585,007
Gross Finite-Lived & Indefinite-Lived Intangible Assets (Note 6)($M)8
44,36544,27144,166
Accumulated Amortization of Intangible Assets($M)
18,85716,94814,932
Indefinite-Lived Intangible Assets (Tradenames)($M)
10,49810,49810,498
Intangible Asset Amortization Expense($M)
431442483500494499503507507508509
Estimated Intangible Amortization — Year 1($M)
1,7171,9812,011
Estimated Intangible Amortization — Year 2($M)
1,6041,7041,964
Estimated Intangible Amortization — Year 3($M)
1,3301,5901,687
Estimated Intangible Amortization — Year 4($M)
1,2521,3161,580
Estimated Intangible Amortization — Year 5($M)
1,2191,2391,306
Trade Accounts Payable & Pharmacy Working Capital Balances($M)4
17,16716,92217,64117,76417,25816,53415,89215,71314,41613,71714,897
Contract Assets, Current (PBM Rebates & Medicare Part D)($M)
12,98512,51110,56311,22110,46510,4509,8819,8849,79310,58611,908
Contract Liabilities, Current($M)
62586165144174128117149
Other Receivables, Net (Manufacturer Rebates & CMS)($M)
6,1116,7047,8999,9799,0538,7607,9666,7324,6343,5303,894
Allowance for Credit Losses on Accounts Receivable($M)
169200182178374392407346355402343
BEA U.S. Personal Consumption Expenditures: Health Care Services (SAAR $B)5
3,790.303,699.903,667.003,614.903,529.803,464.703,417.803,358.203,288.203,244.403,159.40
BEA Real PCE: Health Care Quantity Index (2017=100)(×)
135.90133.60133.60132.70130.40129.00127.90126.70124.80123.80121.50
Census QSS Quarterly Revenue: Ambulatory Health Care Services (NAICS 621)($M)
414,886395,174407,176398,164389,960373,423380,950366,854362,208347,178347,128
Census QSS Quarterly Revenue: Hospitals (NAICS 622)($M)
47,89646,67446,83446,29545,37045,35845,28443,77843,50543,70943,264
Census QSS Quarterly Revenue: Medical and Diagnostic Laboratories (NAICS 6215)($M)
20,52819,56919,99719,67719,71818,72219,10418,89318,48317,96317,943
Census QSS Quarterly Revenue: Outpatient Care Centers (NAICS 6214)($M)
45,10844,02245,30042,79741,83240,03040,60237,89737,22736,08737,030
Peer Benchmark — UnitedHealth Group (UNH): Total Revenues($M)4
112,032111,721113,215113,161111,616109,575100,807100,82098,85599,79694,427
UnitedHealth Group (UNH) — Premiums Revenue($M)
86,95687,56188,81188,97987,90586,53476,48377,44276,89777,98873,228
UnitedHealth Group (UNH) — Medical & Policyholder Benefits Expense($M)
75,35873,48982,04179,95878,58573,41167,03565,95765,45865,73562,231
UnitedHealth Group (UNH) — GAAP Operating Income($M)
7,9918,9903804,3155,1509,1197,7738,7087,8757,9317,689
UnitedHealth Group (UNH) — Medical Costs Payable($M)
38,93039,65939,33740,18138,42737,13634,22433,95132,54734,03232,395
Peer Benchmark — The Cigna Group (CI / Express Scripts): Total Revenues($M)3
71,66868,49472,47269,74867,17865,50265,64963,69460,52357,25551,114
The Cigna Group (CI) — Premiums Revenue($M)
9,8599,8129,2889,0819,15612,73611,50311,43611,45411,60311,175
The Cigna Group (CI) — Medical & Policyholder Benefits Expense($M)
8,4307,9248,2607,8427,74910,49810,1669,5279,5159,4409,280
The Cigna Group (CI) — GAAP Operating Income($M)
2,6762,3582,3452,5782,3061,9712,1732,5762,4122,2562,060
Peer Benchmark — Elevance Health (ELV / Carelon, through Q3 2026): Total Revenues($M)4
51,42950,47450,18149,74750,71149,77648,89145,44245,10643,88642,57742,647
Elevance Health (ELV) — Premiums Revenue($M)
41,70441,27941,02440,69041,79141,27140,88736,24536,80935,41635,69635,138
Elevance Health (ELV) — Benefit Expense($M)
37,77937,02435,61538,06538,14036,70635,31233,50032,94930,57230,54631,334
Elevance Health (ELV) — GAAP Operating Income($M)
1,2691,7632,0863091,2952,4253,1706731,4082,7653,0161,284
Elevance Health (ELV) — Medical Claims Payable($M)
18,43818,46318,42517,08417,14817,15516,81215,74615,34615,20416,45916,111
Peer Benchmark — Humana Inc. (HUM / CenterWell): Total Revenues($M)4
39,64832,51532,64932,38832,11229,21329,39729,54029,61126,462
Humana Inc. (HUM) — Premiums Revenue($M)
37,70930,88430,71130,71630,51427,75027,95128,14228,26125,128
Humana Inc. (HUM) — Benefits Expense($M)
33,70728,72127,99127,56526,53525,38125,12025,03925,12422,782
Humana Inc. (HUM) — GAAP Operating Income($M)
1,754-8084001,0982,014-5437281,1411,236-348
Humana Inc. (HUM) — Benefits Payable($M)
12,6919,96710,08811,06011,45110,44011,12511,44611,72910,241
Peer Benchmark — Centene Corporation (CNC, through Q3 2026): Total Revenues($M)3
50,64753,57949,94449,72549,69048,74246,62040,80542,02339,83640,40739,460
Centene Corporation (CNC) — Medical Costs($M)
41,12839,02938,30341,48940,90238,80836,50331,80932,20130,76530,93230,634
Centene Corporation (CNC) — GAAP Operating Income($M)
-3071,1981,861-1,745-6,954-4581,5341756651,2291,106-194
Centene Corporation (CNC) — Medical Claims Liability($M)
21,49520,26220,62720,54421,49320,11719,91118,30817,99518,17318,10918,000
Peer Benchmark — Molina Healthcare (MOH, through Q3 2026): Total Revenues($M)3
11,08210,87410,79611,37511,47711,42711,14710,49910,3409,8809,9319,048
Molina Healthcare (MOH) — Premium Revenue($M)
10,45710,24410,17210,71510,84110,86810,6289,9839,6949,4469,5048,362
Molina Healthcare (MOH) — GAAP Operating Income($M)
10614583-162137373433380467434426316
Molina Healthcare (MOH) — Medical Claims & Benefits Payable($M)
4,9884,8414,9414,8874,8444,8854,8044,6404,7324,5774,5714,204
Peer Benchmark — HCA Healthcare (HCA) & Labcorp (LH): Provider & Lab Revenues($M)2
19,10919,51319,16118,60518,32118,28517,48717,49217,33917,303
Labcorp Holdings (LH) — Total Revenues($M)
3,7313,5383,5163,5643,5273,3453,3293,2823,2213,1773,033
Labcorp Holdings (LH) — GAAP Operating Income($M)
452381268397394326216254295321-123
DB Segment Context — Health Care Benefits Segment Revenue($M)1
37,53835,97136,29335,99336,25834,81032,95832,99632,47532,23626,726
DB Segment — Health Care Benefits D&A($M)
348340380375419405403407397392
DB Segment Context — Health Services (formerly Pharmacy Services) Segment Revenue($M)1
51,79548,23751,24449,26646,45343,46247,02044,12942,17140,28549,146
DB Segment — Health Services D&A($M)
251258258260260261267267264261
DB Segment Context — Pharmacy & Consumer Wellness (formerly Retail/LTC) Segment Revenue($M)1
33,81631,98937,66036,21433,58131,91233,51432,42329,83828,72531,185
DB Segment — Pharmacy & Consumer Wellness D&A($M)
415406404396389384379387389388
DB Consolidated — Total Revenues($M)11
106,096100,426105,693102,87198,91594,58897,71095,42891,23488,43793,813
DB Consolidated — Net Investment Income($M)
641574594632487520755550394454268
DB Consolidated — Cost of Revenue($M)
58,86255,44459,06057,04554,00551,05755,26852,94849,99848,07357,419
DB Consolidated — Policyholder & Medical Benefits($M)
31,48529,35833,06632,02031,31729,13529,54329,92227,85327,80322,518
DB Consolidated — Operating Income (GAAP)($M)
4,7034,6802,112-3,2072,3813,3742,3688323,0452,2713,373
DB Consolidated — Interest Expense($M)
757774787784763785758752732716690
DB Consolidated — Income Before Income Taxes($M)
3,9773,9381,354-3,4821,6472,6172,1261052,3371,5802,705
DB Consolidated — Income Tax Provision($M)
982981-1,56950863483550334569456658
DB Consolidated — Net Income Attributable to CVS Health($M)
2,9792,9432,943-3,9751,0211,7791,644871,7701,1132,046
DB Consolidated — Diluted EPS (GAAP)($)
2.312.30-3.130.801.410.071.410.88
DB Consolidated — Weighted Average Diluted Shares(M)
1,2871,2791,2691,2701,2641,2591,2591,267
DB Consolidated — Cash Dividends Declared per Share($)
0.670.670.670.670.670.670.670.670.670.670.60
DB Consolidated Balance Sheet — Total Assets($M)11
253,768252,974253,538255,327258,343255,585253,215252,427252,481249,743249,728
DB Balance Sheet — Accounts Receivable, Net($M)
40,30940,99239,77943,85740,65139,62536,46936,17932,38532,21735,227
DB Balance Sheet — Inventories($M)
17,62217,77019,24618,96217,44717,38518,10717,64916,06816,34618,025
DB Balance Sheet — Property and Equipment, Net($M)
13,16813,03713,08312,83812,82512,85612,99312,72813,03213,03713,183
DB Balance Sheet — Operating Lease Right-of-Use Assets($M)
14,45114,74114,97315,27115,51215,70415,94416,23116,90117,04517,252
DB Balance Sheet — Goodwill($M)
85,47885,47885,47885,47891,20391,20391,27291,27291,27291,27291,272
DB Balance Sheet — Intangible Assets, Net($M)
24,64425,07025,50825,98426,22426,57027,32327,81728,31128,77029,234
DB Balance Sheet — Accrued Expenses and Other Liabilities($M)
22,47722,25822,38723,41523,10122,36920,81020,17421,16322,35023,515
DB Balance Sheet — Operating Lease Liabilities($M)
15,38016,65017,775
DB Balance Sheet — Total Liabilities($M)
173,869175,337178,156182,217180,792178,475177,485177,321177,370175,593173,092
DB Balance Sheet — Total Shareholders' Equity($M)
79,89977,63775,38273,11077,55177,11075,73075,10675,11174,15076,636
DB Balance Sheet — Common Shares Outstanding(M)
1,2781,2731,2711,2701,2671,2621,2601,2581,2561,2521,288
DB Consolidated Cash Flow — Operating Cash Flow($M)6
6,3454,2493,3907961,8974,5561,860-7453,0894,903-2,636
DB Cash Flow — Capital Expenditures (Additions to Property & Equipment)($M)
691849784698607743768670638705911
DB Cash Flow — Depreciation and Amortization($M)
1,1261,1151,1471,1341,1711,1541,1471,1611,1511,1381,134
DB Cash Flow — Stock-Based Compensation($M)
176266135138136126137133133137127
DB Cash Flow — Acquisitions (Net of Cash Acquired)($M)
4572901192010124825120
DB Cash Flow — Dividends Paid($M)
878847845846866840838837858840779
DB Cash Flow — Share Repurchases($M)
-0-0-0-0-0133,0271

91 chỉ số không có số liệu trong 12 quý gần nhất — .

In nghiêng là số StockData tự tính từ số đã báo cáo (rê chuột để xem công thức). Số có gạch chân chấm là số đọc từ câu chữ trong thông cáo kết quả và bản trình bày; rê chuột để xem đúng câu đó. Tick vào một dòng để thêm vào biểu đồ phía trên (tối đa 8 đường).

Phương pháp và các chỉ số bị loại
  • Các dòng ở Cốt lõi lấy từ thuyết minh bộ phận và phân tách doanh thu trong hồ sơ 10-K và 10-Q (XBRL), có liên kết tới từng hồ sơ. Số quý 4 bằng cả năm tài chính trừ chín tháng đầu (hiện bằng chữ in nghiêng).
  • Fiscal calendar: CVS Health Corporation operates on a calendar fiscal year ending December 31 (Q1 ends Mar 31, Q2 ends Jun 30, Q3 ends Sep 30, Q4 ends Dec 31). Latest reported company period: Q2 2026 (ended June 30, 2026, filed August 5, 2026 on Form 8-K and Form 10-Q) and Full-Year FY2025 (ended December 31, 2025, filed February 10, 2026 on Form 8-K and Form 10-K). Industry monthly FRED series extend through September 2026 (2026-09) and Managed Care peer XBRL benchmarks (ELV, CNC, MOH) extend through Q3 2026 (FY2026Q3).
  • Q1 2023 Segment Realignment: Effective Q1 2023, CVS Health realigned its segments into Health Care Benefits (Aetna), Health Services (formerly Pharmacy Services, adding Oak Street Health, Signify Health, and MinuteClinic care delivery), and Pharmacy & Consumer Wellness (formerly Retail/LTC, adding mail/specialty fulfillment support and discontinuing the former Maintenance Choice segment reporting practice). Comparative FY2021–FY2022 figures were retrospectively recast in the FY2023 Form 8-K/10-K.
  • Discontinuation of Generic Dispensing Rate (GDR %): Beginning Q1 2025, CVS Health discontinued reporting Generic Dispensing Rate (GDR %) in both Health Services and Pharmacy & Consumer Wellness. Historical GDR series are preserved continuously from FY2017 through FY2024Q4 / FY2024.
  • Subsidiary Self-Reported Disclosures (Group 3): Integrates standalone SEC Form 10-K and Form 10-Q filings of Oak Street Health, Inc. (CIK 0001564406, acquired May 2, 2023), Signify Health, Inc. (CIK 0001828182, acquired March 29, 2023), and Aetna Inc. (CIK 0001122304, acquired November 28, 2018).
  • Parent-Company Standalone Evaluation (Step 3): CVS Health files consolidated US GAAP financial statements without standalone parent-company revenue/operating statements (parent registrant is a holding company with $0 direct operating revenue). Therefore, Consolidated − Standalone subtraction does not apply.
  • Strict Step 4 & Step 5 Compliance: Every cell displays an exact point figure published by CVS Health, its subsidiaries (Oak Street Health, Signify Health, Aetna), or official industry sources (CMS Medicaid Managed Care Enrollment Reports, Census/BLS/BEA via FRED, SEC XBRL peer filings), plus permitted period splits (Q4 = full year − nine months and quarterly cash flow = YTD − prior YTD, marked with formula). Bound/approximate prose figures ('approximately 9,000 retail locations', 'more than 81% of MA members in 4+ star plans' in FY2025, 'more than 3.5 million IHEs', 'approximately 500,000 patients') are excluded and cataloged in `excluded`.

Không hiện vì thiếu các kỳ gần đây (13)

  • Retail pharmacy locations count in Item 1 narrative ('approximately 9,000 retail locations' / 'more than 7,000 retail stores') — Approximate figures ('approximately 9,000', 'more than 7,000') — excluded from table cells; replaced with exact figures from the Store Development Activity table in Item 7 MD&A (8,979 stores at end of FY2025).
  • Retail stores net selling space ('approximately 71.3 million square feet') & distribution centers space ('approximately 10.0 million square feet') — Approximate figures ('approximately 71.3 million', 'approximately 10.0 million') — excluded.
  • Retail pharmacies within chains ('approximately 1,870') and clinics in Target stores ('approximately 30') — Approximate figures ('approximately 1,870', 'approximately 30') from FY2019 onward; state breakdown table only reports data points through FY2017.
  • Medicare Advantage 4.0+ Star plan membership share in FY2025 ('more than 81%' in 4+ star plans; 'more than 63%' in 4.5-star plans) — Approximate figures for FY2025 ('more than 81%', 'more than 63%') — FY2025 data point excluded; exact series retained for FY2015–FY2024 (88% in FY2024, 87% in FY2023).
  • Oak Street Health patients cared for in FY2024–FY2025 ('approximately 500,000 patients') and FY2023 ('approximately 270,000 patients') — Approximate figures ('approximately 500,000', 'approximately 270,000') post-merger into CVS — excluded; exact patient count series retained from Oak Street Health's standalone 10-K/10-Q filings (FY2018–FY2023Q1: 231,000 patients).
  • Signify Health in-home health evaluations (IHEs) volume ('more than 3.5 million IHEs' in FY2025; 'more than 3 million' in FY2024) — Approximate figures ('more than 3.5 million') — excluded; exact Evaluations revenue retained from Signify Health's 10-K/10-Q filings.
  • U.S. retail pharmacy prescription market share ('approximately 28.5%' in FY2025 10-K; 'exceeding 29%' in Q4 2025 presentation) — Approximate figures ('approximately 28.5%', 'exceeding 29%') — excluded.
  • PBM plan members ('approximately 87 million plan members') and retail network size ('approximately 63,000 retail pharmacies') — Approximate figures ('approximately 87 million', 'approximately 63,000') — excluded.
  • Walk-in and primary care medical clinics ('more than 1,000 clinics' / 'more than 800 MinuteClinic locations') — Approximate figures ('more than 1,000', 'more than 800') — excluded.
  • Total workforce headcount ('over 300,000 colleagues', 'approximately 73% full-time') and training hours ('approximately 16 million hours') — Approximate figures ('over 300,000', 'approximately 73%', 'approximately 16 million') — excluded.
  • Health Services retail co-payments included in segment revenue ('approximately $2.1 billion' in Q4 2025; '$10.9 billion' in FY2025) — Approximate figures ('approximately $2.1 billion') in footnotes — excluded.
  • Full-Year 2026 Guidance ranges (Revenues 'At least $414.0B', Adjusted EPS '$7.90 to $8.10', Medical Membership '~26.0M', MBR '89.75% ±25 bps') — Approximate figures / forward-looking guidance ranges ('At least', '~', 'to', '±') — recorded in footnotes & README, excluded from reported actuals.
  • YTD 6-month and 9-month cumulative segment columns in Q2 and Q3 Form 8-K / 10-Q tables — 6-month / 9-month cumulative figures — table fully displays each discrete quarter (Q1, Q2, Q3, Q4) and full year (FY).

Dữ liệu cập nhật 2026-10-28.

Mỗi KPI một trang riêng

Đầy đủ lịch sử, biểu đồ, nguồn và cách trích dẫn cho từng chỉ số

Tài liệu nguồn mới nhất

Các tài liệu được trích nhiều nhất cho số liệu mới nhất của Cvs Health

See a number that looks wrong?